id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-2851-0003,FDA,FDA-2023-N-2851,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2024-02-08T05:00:00Z,2024,2,,,2024-02-08T14:45:17Z,2024-02579,0,0,09000064863f2450
FDA-2023-N-2851-0002,FDA,FDA-2023-N-2851,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Time and Extent Applications for Nonprescription Drug Products,Notice,30 Day Proposed Information Collection,2023-12-08T05:00:00Z,2023,12,2023-12-08T05:00:00Z,2024-01-09T04:59:59Z,2023-12-08T15:05:26Z,2023-26985,0,0,09000064863166bc
FDA-2023-N-2851-0001,FDA,FDA-2023-N-2851,"Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent
Applications for Nonprescription Drug Products",Notice,60 Day Proposed Information Collection,2023-08-08T04:00:00Z,2023,8,2023-08-08T04:00:00Z,2023-10-11T03:59:59Z,2023-08-08T13:03:59Z,2023-16922,0,0,0900006485dfb872